Article Text
Commentary
General medicine
Risk score identifies patients who will benefit from prolonged dual antiplatelet therapy
Statistics from Altmetric.com
Footnotes
Contributors KFF and RWY contributed to the supervision, drafting and critical revision of this manuscript.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.